Na Xiao

机构：Hebei Medical University, Third Hospital of Hebei Medical University · ORCID：0000-0001-9911-3352

发表论文 7 篇 · 总被引 29 次 · h-index 4

代表论文

• Platelet Microparticles: A Tool to Predict Infarction Area in Rats (2019 · Journal of Investigative Surgery · 被引 9)
• Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment (2021 · BMC Pulmonary Medicine · 被引 7)
• Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non–Small Cell Lung Cancer: A Meta-Analysis and Systematic Review (2020 · Frontiers in Pharmacology · 被引 7)
• The impact of preoperative single low-dose dexamethasone on in-hospital prognosis in geriatric intertrochanteric fracture patients: Analysis of secondary outcomes in a randomized controlled trial (2023 · Surgery · 被引 4)
• Identification and validation of key biomarkers of the glycolysis-ketone body metabolism in heart failure based on multi-omics and machine learning (2025 · Frontiers in Cardiovascular Medicine · 被引 1)
• Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer (2021 · Journal of Evidence-Based Integrative Medicine · 被引 1)